Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (21-30 of 464) with videos related to

Pageof 47
Sort By:
The New England Journal of Medicine|August 25, 2016
Ozanimod Treatment for Ulcerative ColitisWilliam J Sandborn, Brian G Feagan
The Cochrane Database of Systematic Reviews|October 19, 2012
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisBrian G Feagan, John K Macdonald
Expert Opinion on Biological Therapy|February 12, 2013
Vedolizumab for Crohn's diseaseMahmoud H Mosli, Brian G Feagan
The Cochrane Database of Systematic Reviews|October 19, 2012
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisBrian G Feagan, John K Macdonald
Gastroenterology Clinics of North America|August 26, 2017
The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better DrugsReena Khanna, Vipul Jairath, Brian G Feagan
Inflammatory Bowel Diseases|May 23, 2018
Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future SolutionsReena Khanna, Guangyong Zou, Brian G Feagan
Expert Opinion on Investigational Drugs|July 4, 2017
Alicaforsen for the treatment of inflammatory bowel diseaseVipul Jairath, Reena Khanna, Brian G Feagan
Inflammatory Bowel Diseases|May 31, 2018
The Role of Biomarkers in Clinical Trials of Inflammatory Bowel DiseaseReena Khanna, Neeraj Narula, Brian G Feagan
Alimentary Pharmacology & Therapeutics|November 30, 2018
Editorial: treating strictures in inflammatory bowel disease-authors' replyFlorian Rieder, Brian G Feagan, Vipul Jairath, et al.
Expert Opinion on Biological Therapy|December 1, 2025
An evaluation of guselkumab for the treatment of ulcerative colitisJurij Hanzel, Vipul Jairath, Brian G Feagan
Pageof 47

Showing results (21-30 of 464) with videos related to

Sort By:
Pageof 47
The New England Journal of Medicine|August 25, 2016
Ozanimod Treatment for Ulcerative ColitisWilliam J Sandborn, Brian G Feagan
The Cochrane Database of Systematic Reviews|October 19, 2012
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisBrian G Feagan, John K Macdonald
Expert Opinion on Biological Therapy|February 12, 2013
Vedolizumab for Crohn's diseaseMahmoud H Mosli, Brian G Feagan
The Cochrane Database of Systematic Reviews|October 19, 2012
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisBrian G Feagan, John K Macdonald
Gastroenterology Clinics of North America|August 26, 2017
The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better DrugsReena Khanna, Vipul Jairath, Brian G Feagan
Inflammatory Bowel Diseases|May 23, 2018
Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future SolutionsReena Khanna, Guangyong Zou, Brian G Feagan
Expert Opinion on Investigational Drugs|July 4, 2017
Alicaforsen for the treatment of inflammatory bowel diseaseVipul Jairath, Reena Khanna, Brian G Feagan
Inflammatory Bowel Diseases|May 31, 2018
The Role of Biomarkers in Clinical Trials of Inflammatory Bowel DiseaseReena Khanna, Neeraj Narula, Brian G Feagan
Alimentary Pharmacology & Therapeutics|November 30, 2018
Editorial: treating strictures in inflammatory bowel disease-authors' replyFlorian Rieder, Brian G Feagan, Vipul Jairath, et al.
Expert Opinion on Biological Therapy|December 1, 2025
An evaluation of guselkumab for the treatment of ulcerative colitisJurij Hanzel, Vipul Jairath, Brian G Feagan
Pageof 47